Synchronous diagnosis of anaplastic large cell lymphoma and multiple myeloma in a patient: A case report
Autor: | Min Chen, Tiantian Li, Yichen Liu, Xiaodong Xi, Wanru Chen, Jian-Nong Wu, Shuo Zhang, Jie Peng, Yan Zhu, Qian Jiang, Xiaofeng Shi, Xianqiu Yu |
---|---|
Rok vydání: | 2020 |
Předmět: |
Skin Neoplasms
co-existence Dexamethasone Neoplasms Multiple Primary 0302 clinical medicine Autologous stem-cell transplantation hemic and lymphatic diseases Positron Emission Tomography Computed Tomography Antineoplastic Combined Chemotherapy Protocols 030212 general & internal medicine Anaplastic large-cell lymphoma Lenalidomide Multiple myeloma Etoposide Remission Induction Hematopoietic Stem Cell Transplantation Bone Marrow Examination General Medicine Middle Aged Immunohistochemistry ALK-negative multiple myeloma Vincristine anaplastic large cell lymphoma 030220 oncology & carcinogenesis Lymphoma Large-Cell Anaplastic Female Radiology medicine.drug Research Article medicine.medical_specialty Transplantation Autologous Maintenance Chemotherapy 03 medical and health sciences Bleomycin medicine Humans Clinical Case Report Cyclophosphamide business.industry Large cell Abdominal Wall medicine.disease Lymphoma Transplantation Regimen Doxorubicin Prednisone business |
Zdroj: | Medicine |
ISSN: | 1536-5964 |
Popis: | Rationale: Synchronous development of both anaplastic large cell lymphoma (ALCL) and multiple myeloma (MM) in a patient is rare. To our knowledge, until now only one case has been reported. Treatment needs to cover both and is a challenge. Here we reported another case and discussed the diagnosis and treatment. Patient concerns: This is a 63-year old woman who presented with a mass in upper abdominal skin. Positron emission tomography/computed tomography (PET/CT) showed the high metabolism in left abdominal skin and left axillary lymph nodes. Histopathologic and immunohistochemical evaluation identified the cutaneous mass as an ALK-negative ALCL. Bone marrow smear showed increased plasma cells which expressed CD38, CD138, and cLambda concomitantly. The increased monoclonal immunoglobulin IgD λ was detected by immunofixation electrophoresis. Diagnoses: Diagnosis of both ALCL and MM was confirmed. Interventions: The patient successively received 6 cycles of B-CHOD regimen, one cycle of ID regimen, 2 cycles of DHAX regimen, one cycle of L-DA-EPOCH and autologous stem cell transplantation (ASCT). Then lenalidomide was performed as a maintenance therapy. Outcomes: Both ALCL and MM achieved complete remission. Lessons: We reported a very rare case with synchronous development of ALCL and MM, in whom a good therapeutic response to chemotherapies followed by ASCT has been observed. |
Databáze: | OpenAIRE |
Externí odkaz: |